Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease – a case report

Autor: Veronika Elisakova, Miroslav Merta, Jana Reiterova, Alica Baxova, Jaroslav Kotlas, Katerina Hirschfeldova, Lena Obeidova, Vladimir Tesar, Jitka Stekrova

Publikováno v: BMC Nephrology, Vol 19, Iss 1, Pp 1-7 (2018)

Abstract Background Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal disorder, leading to end stage renal failure and kidney transplantation in its most serious form. The severity of the disease’s manifestati

Externí odkaz: https://doaj.org/article/a4bd93f497214e91a08c006bd6bb99c3

Protein kinase D interacts with adaptor protein Ruk/CIN85 and phosphorylates it

Autor: Yu. A. Rzepetsky, A. A. Samoylenko, O. P. Kukharenko, S. V. Mikhalap, S. P. Sidorenko, A. Hausser, L. B. Drobot

Publikováno v: Біологічні студії, Vol 3, Iss 3, Pp 17-28 (2009)

Adaptor protein Ruk/CIN85 is built of multiple domains and motives involved in the intermolecular interactions. It functions as a key component of signalling networks that controls important cellular responses in coordinated fashion. The presence of

Externí odkaz: https://doaj.org/article/cb918d8da6bf470ab0962bd9d00c9c22

Protein kinase D interacts with adaptor protein Ruk/CIN85 and phosphorylates it

Autor: A. Hausser, L. B. Drobot, O. P. Kukharenko, A. A. Samoylenko, Svetlana P. Sidorenko, S. V. Mikhalap, Yu. А. Rzepetsky

Publikováno v: Біологічні студії, Vol 3, Iss 3, Pp 17-28 (2009)

Adaptor protein Ruk/CIN85 is built of multiple domains and motives involved in the intermolecular interactions. It functions as a key component of signalling networks that controls important cellular responses in coordinated fashion. The presence of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d815ecb470861859160d7f0c5aa411cc
https://doi.org/10.30970/sbi.0303.050

Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.

Autor: Masyuk T; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Masyuk A; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Trussoni C; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Howard B; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Ding J; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Huang B; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., LaRusso N; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

Publikováno v: JHEP reports : innovation in hepatology [JHEP Rep] 2021 Aug 05; Vol. 3 (5), pp. 100345. Date of Electronic Publication: 2021 Aug 05 (Print Publication: 2021).